Loading...
Loading...
GRNA| Name | Value |
|---|---|
| Revenues | 3.8M |
| Cost of Revenue | 0.0M |
| Gross Profit | 3.8M |
| Operating Expense | 32.1M |
| Operating I/L | -28.3M |
| Other Income/Expense | -0.2M |
| Interest Income | 0.6M |
| Pretax | -28.5M |
| Income Tax Expense | -0.4M |
| Net Income/Loss | -28.0M |
GreenLight Biosciences Holdings is a biotechnology company specializing in the manufacturing and sale of ribonucleic acid (RNA) products. The company's revenue is generated through the production and sale of mRNA vaccines and therapeutics for human health, as well as agricultural RNA products designed to protect honeybees and crops. With a focus on RNA-based solutions, the company serves both the human health and agriculture sectors, leveraging its expertise in RNA technology to address critical needs in these industries.
